ArticleClinicoEconomics and outcomes research : CEOR2016

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.

Oskar Eklund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.